Sanofi
As of Oct 22, 2026 close
- Market cap
- $100.42B
- P/E (TTM)
- 22.63
- Forward P/E
- 40.00
- Dividend yield
- 5.77%
- 52-week range
- $39.07$52.68
- Volume (live)
- -
- Avg. volume (3M)
- 3.36M
Sanofi (SNY) Stock Price & Financial Analysis
Sanofi Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $41.07 - $42.11 |
|---|---|
| 52-Week High | $52.68 |
| 52-Week Low | $39.07 |
| Open | $41.17 |
| Volume (last close) | 3.46M |
| Average Volume (3M) | 3.36M |
| Revenue (TTM) | 54.84B |
|---|---|
| Net Income (TTM) | 4.44B |
| Free Cash Flow (TTM) | 11.15B |
| EPS (TTM) | $2.10 |
| Profit Margin | 8.09% |
| Operating Margin | 14.80% |
| Return on Equity (ROE) | 5.72% |
| Debt to Equity | 0.34 |
| Annual Dividend | $2.42 |
|---|---|
| Dividend Yield | 5.77% |
| Payout Ratio | 115.45% |
| Last Dividend Ex-Date | May 4, 2026 |
| Market Cap | 100.42B |
|---|---|
| Shares Outstanding | 2.39B |
| P/E Ratio (TTM) | 22.63 |
| Forward P/E | 40.00 |
| Price to Sales (P/S) | 1.83 |
| Price to Book (P/B) | 1.29 |
| EV/EBITDA | 8.60 |
| 50-Day MA | $42.55 |
|---|---|
| 200-Day MA | $44.56 |
| 1-Year Change | −15.27% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Sanofi at a Glance
As of the Oct 22, 2026 close, Sanofi (SNY) has a market capitalization of $100.42B. The stock trades at 22.6× trailing earnings, 40.0× forward earnings and 1.8× sales. Over the trailing twelve months it earned $4.44B on revenue of $54.84B (a 8.1% profit margin) and generated $11.15B of free cash flow. Revenue grew 4.3% year over year.
As of its latest reported balance sheet, it holds $7.12B in cash and securities against $26.43B of debt, a net debt position of $19.31B.
Sanofi pays a annual dividend totaling $2.42 per share a year, a 5.77% yield at the Oct 22, 2026 close, with a 115% payout ratio and 3 consecutive years of dividend increases.
The share price is down 15.3% over the past year. At $41.96 (the Oct 22, 2026 close) it sits within its 52-week range of $39.07 to $52.68, below its 200-day moving average of $44.55.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $59.50, 41.8% above the Oct 22, 2026 close.
Frequently Asked Questions About Sanofi
What is the current stock price for SNY?
As of the Oct 22, 2026 close, SNY stock trades at $41.96. The 52-week range is $39.07–$52.68, with a day range of $41.07–$42.11.
What is the P/E ratio for SNY?
As of the Oct 22, 2026 close, Sanofi's trailing twelve-month (TTM) P/E ratio is 22.6, meaning investors pay $22.6 for every $1 of annual earnings. The forward P/E is 40.0, reflecting analyst expectations for future earnings. Sanofi operates in the Healthcare sector.
Does SNY pay dividends?
Yes, Sanofi pays a 5.77% annual dividend yield as of the Oct 22, 2026 close ($2.42 per share a year). The trailing twelve-month payout ratio is 115.5%. The most recent ex-dividend date was May 4, 2026.
What do analysts recommend for SNY?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for SNY is Buy. The average 12-month price target is $59.50, a 41.8% upside from the Oct 22, 2026 close of $41.96.
What is the market cap of SNY?
As of the Oct 22, 2026 close, Sanofi's market capitalization is $100.42B, classifying it as a large-cap company. Sanofi operates in the Healthcare sector within the Drug Manufacturers - General industry.